IRVINE, Calif., April 24, 2017 -- Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) announced today that it will issue its 2017 first quarter earnings release on May 8, 2017.
A conference call with a simultaneous webcast to discuss the 2017 first quarter earnings will be held on Tuesday, May 9 at 10:00 a.m. Pacific Time. The dial in number for the conference call is 800-946-0785 and participants should reference SABRA.
The webcast URL is http://edge.media-server.com/m/p/gdeddewz.
A digital replay of the call will also be available for 30 days following the call, by dialing 888-203-1112 and using the passcode 7967960.
ABOUT SABRA
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.
Contact: Investor & Media Inquiries: (888) 393-8248


Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Google Secures Pentagon AI Deal for Classified Projects
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 



